Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures

ICR 201711-0651-014

OMB: 0651-0024

Federal Form Document

Forms and Documents
Document
Name
Status
Form
Unchanged
Justification for No Material/Nonsubstantive Change
2017-11-15
Supporting Statement A
2016-05-27
Supplementary Document
2016-05-27
Supplementary Document
2016-05-27
Supplementary Document
2016-05-27
ICR Details
0651-0024 201711-0651-014
Historical Inactive 201605-0651-002
DOC/PTO
Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures
Revision of a currently approved collection   No
Regular
Improperly submitted and continue 12/11/2017
Retrieve Notice of Action (NOA) 11/17/2017
To be resubmitted as a change request.
  Inventory as of this Action Requested Previously Approved
07/31/2019 07/31/2019 07/31/2019
27,200 0 27,200
152,285 0 152,285
1,815,458 0 1,815,458

Patent applications that contain nucleotide and/or amino acid sequence disclosures must include a copy of the sequence listing in accordance with the requirements in 37 CFR 1.821-1.825. Applicants submit copies of sequence listings for both U.S. and international biotechnology patent applications. The USPTO uses the sequence listings during the examination process to determine the patentability of the associated patent application. The USPTO also uses the sequence listings to support publication of patent applications and issued patents. Sequence listings are searchable after publication.

US Code: 35 USC 22 Name of Law: null
  
None

0651-AD02 Final or interim final rulemaking 82 FR 52780 11/14/2017

  81 FR 14425 03/17/2016
81 FR 33480 05/26/2016
No

No
No

$446,015
No
    No
    No
No
No
No
Uncollected
Raul Tamayo 571 272-7728 raul.tamayo@uspto.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
11/17/2017


© 2024 OMB.report | Privacy Policy